Stockscreener 앱 받기
6.61
0.00%
0.00
Tango Therapeutics Inc 주식(TNGX)의 최신 뉴스
What’s next for Tango Therapeutics Inc. stock priceDay Trading Setup and Momentum Analysis - Newser
Will Tango Therapeutics Inc. see short term momentumTrade Plan With Low Risk High Return - Newser
How moving averages guide Tango Therapeutics Inc. tradingFree Low Risk Picks for Daily Trading - Newser
What candlestick patterns are forming on Tango Therapeutics Inc.Machine Learning Stock Price Forecast Tool - Newser
Why Tango Therapeutics Inc. stock attracts strong analyst attentionStrong Buy Signal Summary with Entry Zone - Newser
Tango Therapeutics Inc. recovery potential after sell offDaily Market Momentum and Pressure Analysis - Newser
What Fibonacci levels say about Tango Therapeutics Inc. reboundFree Short Term Buy List With Stop Protection - Newser
How high can Tango Therapeutics Inc. stock price go in 2025Trend Reversal Watch with Entry Signals - Newser
Advanced analytics toolkit walkthrough for Tango Therapeutics Inc.Buy Strategy Tracker with Growth Indicators - Newser
Cantor Fitzgerald Issues Positive Forecast for TNGX Earnings - Defense World
Full technical analysis of Tango Therapeutics Inc. stockFree Strong Buy With Technical Confidence - Newser
Price action breakdown for Tango Therapeutics Inc.Volume Spike Detection for Early Breakouts - Newser
Wedbush Forecasts Stronger Earnings for Tango Therapeutics - Defense World
What machine learning models say about Tango Therapeutics Inc.Safe Entry Screening with Data Backed Analysis - Newser
Tango Therapeutics: Guggenheim Raises PT to $10, Maintains Buy Rating - AInvest
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates - MSN
Tango Therapeutics Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Bank of New York Mellon Corp Acquires 10,213 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World
Tango Therapeutics 2025 Q2 Earnings Misses Targets as Net Loss Widens 52% - AInvest
Tango Therapeutics Reports Q2 2025 Financial Results - TipRanks
Tango (TNGX) Q2 Revenue Drops 52% - The Globe and Mail
Tango (TNGX) Q2 Revenue Drops 52% - The Motley Fool
Revolution Medicines shares rise 2.80% intraday after Tango Therapeutics reported dosing first patient in combination trial with Revolution Medicines RAS(ON) inhibitors. - AInvest
Navigating the Crossroads: Tango Therapeutics' Financial Resilience and the Road to Long-Term Value Creation - AInvest
Tango Therapeutics earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Tango Therapeutics earnings matched, revenue fell short of estimates - Investing.com
Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - The Manila Times
Tango Therapeutics, Inc. SEC 10-Q Report - TradingView
Tango Therapeutics Q2 revenue drops, net loss widens - MarketScreener
Analyzing Tango Therapeutics Inc. with risk reward ratio chartsLong Term Equity Screener with Safety Metrics - Newser
Technical Charts Suggest Momentum Shift in Tango Therapeutics Inc.Trend Analysis for Safer Trades Gains Popularity - metal.it
Will Tango Therapeutics (NASDAQ:TNGX) Spend Its Cash Wisely? - Yahoo Finance
Is Tango Therapeutics Inc. stock bottoming outSmart Trade Forecast Based on Neural Logic - Newser
Can Tango Therapeutics Inc. stock recover from recent declinePredictable Income Summary for Long-Term Trades - Newser
Should I hold or sell Tango Therapeutics Inc. stock in 2025Build a portfolio that outperforms the market - Jammu Links News
Applying Elliott Wave Theory to Tango Therapeutics Inc.Smart Entry Signals for Active Traders - Newser
Published on: 2025-08-04 03:00:28 - Jammu Links News
How volatile is Tango Therapeutics Inc. stock compared to the marketInvest smarter with daily trading signals - Jammu Links News
What is the risk reward ratio of investing in Tango Therapeutics Inc. stockGet alerts on high-potential stock breakouts - Jammu Links News
What are the latest earnings results for Tango Therapeutics Inc.Explosive capital appreciation - Jammu Links News
Will Tango Therapeutics Inc. outperform the marketFree Capital Preserving Trade Plan Templates - Newser
How does Tango Therapeutics Inc. compare to its industry peersRealize exceptional returns through smart trading - Jammu Links News
What institutional investors are buying Tango Therapeutics Inc. stockBuild wealth steadily with smart stock selection - Jammu Links News
Does Tango Therapeutics Inc. stock perform well during market downturnsBuild wealth steadily with proven stock picks - Jammu Links News
What are Tango Therapeutics Inc. company’s key revenue driversInvest smarter with data-backed insights - Jammu Links News
How does Tango Therapeutics Inc. generate profit in a changing economyBuild your wealth with consistent stock growth - Jammu Links News
Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect? - MSN
0.24%
3.39%
자본화:
|
볼륨(24시간):